🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Aim and objectives: This trial aims to evaluate the role of adjuvant radio...
Status
Active Not Recruiting
Location
Tata Memorial Centre
Start Date
2016-06-02
Trial ID
NCT02951325
Treatments Being Tested
This phase I trial studies on how the PEOX-based polymer encapsulated pacli...
Status
Terminated
Location
Los Angeles General Medical Center
Start Date
2024-04-01
Trial ID
NCT06338657
This registry will collect data from patients routinely undergoing an ERCP ...
Status
Completed
Location
University of Colorado Hospital
Start Date
2008-11
Trial ID
NCT00779688
Treatments Being Tested
In this prospective study, 68Ga-PSMA integrated PET/MR imaging was applied ...
Status
Unknown
Location
China, Hubei Province
Start Date
2021-08-16
Trial ID
NCT05006326
The goal of this clinical trial is to compare breath samples from patients ...
Status
Terminated
Location
Vitalite Health Network
Start Date
2023-04-24
Trial ID
NCT06288646
Bladder cancer is a highly heterogeneous malignancy characterized by freque...
Status
Recruiting
Location
The Second Hospital of Lanzhou University
Start Date
2026-02-25
Trial ID
NCT07424560
Treatments Being Tested
This study is being performed to verify the ability to use minimally invasi...
Status
Terminated
Location
University of California, Irvine Health
Start Date
2013-06
Trial ID
NCT02307552
Treatments Being Tested
This phase I/II trial tests the safety, side effects best dose and effect o...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-06-23
Trial ID
NCT07468136
The goal of this study is to develop, optimize, and validate a High Resolut...
Status
Completed
Location
Lyndon B. Johnson General Hospital
Start Date
2015-04
Trial ID
NCT02340650
Bladder cancer is one of the most common cancer worldwide and the second mo...
Status
Completed
Location
Groupement des Hôpitaux de l'Institut Catholique de Lille
Start Date
2016-07
Trial ID
NCT02857634
Treatments Being Tested